Skip to content
★ Sign in to follow
LL
Total declarations
3
Company
1
▲ Purchases (1 ops.)
€10k
▼ Sales (1 ops.)
€52k

Latest filing published 09 Jan 2015 for Altimmune, Inc., €28k.

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Linda L. Chang: trading record in brief

This profile gathers the share dealings of Linda L. Chang in Altimmune, Inc. The record holds 3 filings, for trades running from 16 November 2011 to 7 January 2015.

Market trades split into 1 purchase (€10k) and 1 sale (€52k). Taken together, the sales exceed the purchases by €42k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 option exercise. 2015 to date brings no purchases and 1 sale.

The newest entry dates from 9 January 2015: an option exercise of €28k, in Altimmune, Inc. The last insider purchase was made public on 18 November 2011, 5,470 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Linda L. Chang

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ◇
    SVP, CFO & SecretaryExecutivesAltimmune, Inc.
    33,448 USD0SEC
    29,600 shares@ US$1.13Common Stock, $0.0001 par value per shareSEC:0001144204-15-001664:0
  • ▼
    SVP, CFO & SecretaryExecutivesAltimmune, Inc.
    62,160 USD0SEC
    29,600 shares@ US$2.10Common Stock, $0.0001 par value per shareSEC:0001144204-15-001664:1
  • ▲
    SVP & CFOExecutivesAltimmune, Inc.
    13,800 USD0SEC
    10,000 shares@ US$1.38Common Stock, $0.0001 par value per shareSEC:0001144204-11-065758:0
    Canonical exit: 14 Feb 2012 (T+90)

3 of 3 declarations